Get frequent stock market updates that focus on broad U.S. and international markets approximately every half-hour starting at 6 a.m. ET with foreign market and U.S. futures summaries and market briefs. Get up to speed on premarket activity such as stock specific news headlines, ratings changes, earnings, economic events, and futures as well as overnight developments from Asian and European equity and foreign exchange market activity. After the open, not only will our market briefing keep you updated on market action, data, and events, but we’ll also keep you abreast of sector and industry performance as well as market sentiment and flow. Shortly after the close, our final stock market update provides a concise review of the day’s market action and events and highlights key items that may have an impact on the stock market on the following trading day.
Dow | 44911.82 | -34.30 | (-0.08%) |
Nasdaq | 21628.39 | +6.80 | (0.03%) |
SP 500 | 6449.15 | -0.65 | (-0.01%) |
10-yr Note | |||
NYSE | Adv 1517 | Dec 1218 | Vol 1.00 bln |
Nasdaq | Adv 2487 | Dec 2051 | Vol 8.28 bln |
Strong: Consumer Staples, Industrials, Consumer Discretionary, Financials, Information Technology |
Weak: Communication Services, Energy, Materials, Real Estate, Utilities, Health Care |
September rate cut expectations continue to drive the market ahead of Fed Chair Powell's Friday address Lack of macro drivers today as the market awaits a slate of earnings reports from major retailers later in the week |
[BRIEFING.COM] The stock market drifted sideways throughout the entirety of today's session as a light batch of headlines and the anticipation of key drivers later in the week culminated in a palpable lack of conviction. The S&P 500 (flat), Nasdaq Composite (flat), and DJIA (-0.1%) traded in a tight range, never staying decidedly above or below their flatlines and failing to challenge record high levels from the previous week.
The market is awaiting the Fed’s Jackson Hole Symposium that kicks off on Thursday, with Fed Chair Jerome Powell's Friday address arguably the most anticipated development of the week. There is currently an 83.2% probability of a 25-basis point cut at the September FOMC meeting, according to the CME FedWatch Tool. Market participants will be listening closely to see if Mr. Powell plays into the market’s prevailing view or tries to temper it.
President Trump's Friday meeting with Russia's President Putin did not produce any immediate agreements, but it led to more talks in Washington, this time with European leaders, including the Ukrainian president. The hope is now that a trilateral meeting between leaders from the U.S., Ukraine, and Russia will take place soon.
Today's action, or lack thereof, reflected an uncertainty in the market's direction as it relates to economic policy, with little corporate or earnings news to stimulate excitement.
Breadth figures were relatively even throughout the session, with advancers outpacing decliners by a roughly 5-to-4 margin on the NYSE and a roughly 11-to-9 clip on the Nasdaq.
Five S&P 500 sectors finished in positive territory, led by the industrials sector (+0.4%), which saw a substantial gain in one of its smaller components, Dayforce (DAY 66.62, +13.74, +25.98%), after Bloomberg reported that Thomas Bravo is in talks to acquire the company.
The consumer discretionary sector (+0.4%) also captured a nice gain as Tesla (TSLA 335.16, +4.60, +1.39%) was the best-performing mega-cap stock on an otherwise lackluster day for the Magnificent 7.
The information technology (+0.1%), financials (+0.1%), and consumer staples (+0.1%) sectors rounded out the five advancing sectors. The real estate (-1.0%), communication services (-0.7%), energy (-0.6%), materials (-0.6%), utilities (-0.5%), and health care (-0.2%) sectors closed with losses.
The communication services sector spent the entirety of the session among the worst-performing sectors, nursing a loss in Meta Platforms (META 767.37, -17.86, -2.27%) that saw the Vanguard Mega Cap Growth ETF (-0.1%) close with a modest loss.
The health care sector spent most of the day at the top of the leaderboard in what at the time appeared to be a continuation of last week's trend, but lost its momentum.
CVS Health (CVS 70.16, +1.57, +2.29%) traded higher after UBS upgraded the stock to Buy from Neutral with a target of $79. While not in the S&P 500, Novo Nordisk A/S (NVO 53.78, +1.36, +2.60%) generated some early buzz after its Wegovy drug was approved for the treatment of noncirrhotic MASH with moderate to advanced liver fibrosis. The company also announced it will offer its GLP-1 drugs, Ozempic (for diabetes) and Wegovy (for weight loss), at a cash price of $499 per month to self-paying patients through GoodRx (GDRX 5.12, +1.39, +37.27%).
Despite the broader market losing much of last week's momentum, smaller-cap stocks continued their trend of outperformance. The Russell 2000 advanced 0.4% today, and the S&P Mid Cap 400 gained 0.2%.
Retailers also traded generally higher today in anticipation of some key names reporting earnings this week, including Walmart (WMT 100.68, +0.68, +0.68%), Costco (COST 979.35, +7.31, +0.75%), Home Depot (HD 394.70, -4.68, -1.17%), and Target (TGT 104.97, +1.95, +1.89%). The SPDR S&P Retail ETF finished with a gain of 0.9%.
U.S. Treasuries started the week on a slightly lower, but generally quiet, note. The 2-year note yield settled up one basis point to 3.77% and the 10-year note yield settled up one basis point to 4.34%.
Reviewing today's data:
[BRIEFING.COM] The major averages are little changed from previous levels as the market enters the final half hour of trading.
President Trump and Ukrainian President Volodymyr Zelenskyy are currently meeting with a coalition of European leaders at the White House to discuss a peace negotiation between Ukraine and Russia, with a trilateral meeting between the three presidents a proposed next step.
The negotiations have not had much effect on the direction of the market, which has drifted sideways as the market anticipates more tangible drivers later in the week.
[BRIEFING.COM] The S&P 500 (flat), DJIA (-0.1%), and Nasdaq Composite (flat) sit in a mixed fashion on an uneventful Monday session.
The health care sector (flat) spent much of the morning as the top-performing S&P 500 sector but has since seen its gains erased, with its largest component, Eli Lilly (LLY 699.69, -1.54, -0.22%), now facing a loss on the day.
Meanwhile, the consumer discretionary sector (+0.4%) now leads the advancing sectors, as Tesla (TSLA 334.94, +4.38, +1.32%) sees the lion's share of what little mega-cap strength is around today.
Elsewhere in the sector, Bloomberg reports that Starbucks (SBUX 92.66, +2.06, +2.27%) will raise salaries 2% this year as part of an initiative to improve customer experience within its stores.
[BRIEFING.COM] The S&P 500 (-0.08%) is in second place on Monday afternoon, down about five points.
Briefly, S&P 500 constituents First Solar (FSLR 220.57, +20.62, +10.31%), The Trade Desk (TTD 55.12, +3.00, +5.76%), and lululemon athletica (LULU 206.56, +8.10, +4.08%) pepper the top of the standings. FSLR shares are rallying after the U.S. issued favorable safe harbor tax credit guidance that eased retroactivity fears, preserved key incentives, and boosted clarity for utility-scale projects, removing a major overhang for the sector, while LULU continues last week's strength.
Meanwhile, EQT Corp. (EQT 50.16, -2.69, -5.09%) is today's worst laggard, slipping after Roth Capital downgraded shares to Neutral warning that gas oversupply may pressure prices through 2026.
[BRIEFING.COM] The Nasdaq Composite (-0.13%) is in last place on Monday afternoon, down about 28 points.
Gold futures settled less than $4.60 lower (-0.1%) at $3,378.00/oz, driven by a modest easing of safe-haven demand amid improving risk sentiment and rising yields. Market optimism around a potential Ukraine peace deal, coupled with expectations of a U.S. Federal Reserve interest-rate cut in September, has reduced gold's relative appeal, particularly as global equities rally and corporate earnings remain strong.
Meanwhile, the U.S. Dollar Index is up +0.3% to $98.14.